About Comprehensive Hemophilia Care Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Comprehensive Hemophilia Care Center
During the past decade, Comprehensive Hemophilia Care Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes
1999-03-01
2012-12-01
Completed
5,351
Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
2000-02-01
2019-11-01
Completed
2,130
Exemestane in Treating Postmenopausal Women With Resected Stage I, Stage II, or Stage IIIA Breast Cancer Who Have Completed 5 Years of Tamoxifen
2001-05-01
2011-02-01
Completed
1,598
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Fruit and Vegetable Extracts in Treating Patients With Stage I-IV, Stage IVA/IVB Head and Neck Cancer
2004-01-01
2009-04-01
Completed
134
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-12-17
2025-12-01
Active, not recruiting
3,066
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Comprehensive Hemophilia Care Center
According to Clinical.Site data, the most researched conditions in "Comprehensive Hemophilia Care Center" are
"Hemophilia A With Inhibitor" (1 trials), "Hemophilia A or B With Inhibitor" (1 trials) and "Hemophilia B With Inhibitor" (1 trials). Many other conditions were trialed in "Comprehensive Hemophilia Care Center" in a lesser frequency.
Clinical Trials Intervention Types at Comprehensive Hemophilia Care Center
Most popular intervention types in "Comprehensive Hemophilia Care Center" are "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Biosimilar eptacog alfa, activated (AryoSeven)" (1 trials), "Eptacog alfa, activated" (1 trials) and "Eptacog alfa, activated (Novoseven)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Comprehensive Hemophilia Care Center
The vast majority of trials in "Comprehensive Hemophilia Care Center" are
2 trials for "Male" genders.
Clinical Trials Status at Comprehensive Hemophilia Care Center
Currently, there are NaN active trials in "Comprehensive Hemophilia Care Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Comprehensive Hemophilia Care Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Comprehensive Hemophilia Care Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".